HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Massimo Negrini Selected Research
Massimo Negrini Research Topics
Disease
84
Neoplasms (Cancer)
06/2023 - 01/2003
21
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2019 - 11/2002
18
Carcinogenesis
12/2021 - 08/2003
17
Hepatocellular Carcinoma (Hepatoma)
11/2023 - 07/2007
10
Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 01/2003
10
Breast Neoplasms (Breast Cancer)
12/2018 - 01/2005
9
Neoplasm Metastasis (Metastasis)
11/2021 - 02/2007
8
Chromosome Aberrations (Chromosome Abnormalities)
12/2015 - 08/2003
7
Liver Neoplasms (Liver Cancer)
12/2022 - 12/2011
7
Disease Progression
08/2022 - 10/2005
6
Leukemia
06/2015 - 08/2004
5
Melanoma (Melanoma, Malignant)
07/2022 - 01/2013
5
Carcinoma (Carcinomatosis)
08/2021 - 01/2003
4
Hypoxia (Hypoxemia)
01/2023 - 03/2007
4
Colonic Neoplasms (Colon Cancer)
08/2021 - 08/2007
3
Lymphoma (Lymphomas)
01/2019 - 01/2005
2
Glioma (Gliomas)
09/2022 - 05/2016
2
Infections
02/2022 - 01/2005
2
Ewing Sarcoma (Sarcoma, Ewing)
01/2022 - 04/2012
2
Fibrosis (Cirrhosis)
11/2019 - 03/2019
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 01/2015
2
Malignant Mesothelioma
12/2016 - 05/2011
2
Sarcoma (Soft Tissue Sarcoma)
01/2015 - 01/2005
2
Trisomy (Trisomies)
08/2014 - 10/2009
2
Hematologic Neoplasms (Hematological Malignancy)
10/2013 - 05/2006
2
Chromosomal Instability (Chromosome Stability)
09/2013 - 10/2002
2
Multiple Myeloma
11/2012 - 10/2012
2
Stomach Neoplasms (Stomach Cancer)
09/2012 - 03/2008
2
B-Cell Lymphoma (Lymphoma, B Cell)
09/2012 - 09/2005
2
Neoplastic Cell Transformation
06/2007 - 03/2007
2
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2007 - 01/2003
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2003 - 05/2002
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023
1
Vulvar Lichen Sclerosus
01/2023
1
Brain Injuries (Brain Injury)
09/2022
1
Hypothermia
09/2022
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2022
1
Adenocarcinoma of Lung
08/2022
1
Prostatic Neoplasms (Prostate Cancer)
07/2022
1
COVID-19
02/2022
1
Communicable Diseases (Infectious Diseases)
02/2022
1
Cytokine Release Syndrome
02/2022
1
Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2021
1
Type 2 Diabetes Mellitus (MODY)
11/2019
1
Liver Cirrhosis (Hepatic Cirrhosis)
11/2019
Drug/Important Bio-Agent (IBA)
84
MicroRNAs (MicroRNA)
IBA
01/2023 - 11/2002
20
Biomarkers (Surrogate Marker)
IBA
07/2022 - 10/2009
18
Proteins (Proteins, Gene)
FDA Link
01/2023 - 01/2003
11
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 10/2002
6
Messenger RNA (mRNA)
IBA
08/2022 - 08/2007
5
Sorafenib (BAY 43-9006)
FDA Link
06/2023 - 07/2017
5
Long Noncoding RNA
IBA
10/2018 - 01/2010
4
nuclear pore complex protein 98
IBA
05/2006 - 05/2002
3
RNA (Ribonucleic Acid)
IBA
08/2022 - 12/2014
3
Mitogens
IBA
09/2018 - 03/2012
3
Untranslated RNA (Noncoding RNA)
IBA
01/2016 - 09/2007
3
Tumor Biomarkers (Tumor Markers)
IBA
06/2015 - 01/2003
2
palbociclib
IBA
12/2022 - 09/2022
2
Cell-Free Nucleic Acids
IBA
08/2022 - 12/2018
2
Transcription Factors (Transcription Factor)
IBA
01/2022 - 01/2015
2
Monoclonal Antibodies
IBA
01/2019 - 10/2015
2
Glucose (Dextrose)
FDA Link
Generic
10/2018 - 05/2016
2
Oxygen (Dioxygen)
IBA
10/2018 - 03/2007
2
Phosphotransferases (Kinase)
IBA
01/2018 - 01/2008
2
Asbestos
IBA
12/2016 - 05/2011
2
Methyltransferases
IBA
05/2016 - 01/2003
2
Panitumumab (Vectibix)
FDA Link
11/2015 - 10/2015
2
Cetuximab (Erbitux)
FDA Link
11/2015 - 10/2015
2
ErbB Receptors (EGF Receptor)
IBA
10/2015 - 01/2015
2
Paraffin
IBA
01/2015 - 09/2011
2
Formaldehyde (Formol)
FDA Link
01/2015 - 09/2011
2
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2014 - 06/2010
2
Luciferases
IBA
10/2013 - 05/2010
2
Oligonucleotides
IBA
01/2013 - 09/2012
2
mouse MIRN29 microRNA
IBA
10/2012 - 10/2009
2
Cyclin-Dependent Kinases (cdk Proteins)
IBA
09/2012 - 01/2011
2
Cyclin G1
IBA
07/2009 - 07/2007
2
Nucleotides
IBA
01/2008 - 07/2007
2
Tumor Viral Antigens (Large T Antigen)
IBA
01/2004 - 08/2003
2
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
01/2004 - 08/2003
1
atezolizumab
IBA
11/2023
1
Bevacizumab (Avastin)
FDA Link
11/2023
1
Glycogen
IBA
06/2023
1
Small Interfering RNA (siRNA)
IBA
01/2023
1
Melatonin
IBA
09/2022
1
Imatinib Mesylate (Gleevec)
FDA Link
08/2022
1
Class 5 Receptor-Like Protein Tyrosine Phosphatases
IBA
08/2022
1
Tyrosine Kinase Inhibitors
IBA
08/2022
1
Chemokines
IBA
02/2022
1
Cytokines
IBA
02/2022
1
Zyxin
IBA
01/2022
1
EWS-FLI fusion protein
IBA
01/2022
1
1-methyl-1-piperidinomethane sulfonate
IBA
12/2021
1
Protein Isoforms (Isoforms)
IBA
12/2021
1
Purinergic P2X7 Receptors
IBA
11/2021
1
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2021
1
Epithelial Cell Adhesion Molecule
IBA
01/2020
1
Lipids
IBA
11/2019
Therapy/Procedure
20
Therapeutics
07/2022 - 02/2003
4
Drug Therapy (Chemotherapy)
11/2019 - 01/2016